Public Sector Pension Investment Board I Teos Therapeutics, Inc. Transaction History

Public Sector Pension Investment Board

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 22, 2023	SELL	$10.95 - $14.6 $121,260 - $161,680	-11,074 Reduced 25.28%	32,728 $358,000
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.05 $8,145 - $11,371	630 Added 1.46%	43,802 $579,000
Q1 2023 May 12, 2023	SELL	$13.02 - $22.62 $23,722 - $41,213	-1,822 Reduced 4.05%	43,172 $587,000
Q3 2022 Nov 14, 2022	BUY	$18.6 - $27.25 $138,086 - $202,304	7,424 Added 19.76%	44,994 $857,000
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $1.2 Million - $1.78 Million	37,570 New	37,570 $1.21 Million

169

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $285M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

Stay updated on Public Sector Pension Investment Board with notifications on news.